• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杜氏肌营养不良症上肢功能患者报告结局量表的开发:DMD上肢PROM

Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM.

作者信息

Klingels K, Mayhew A G, Mazzone E S, Duong T, Decostre V, Werlauff U, Vroom E, Mercuri E, Goemans N M

机构信息

Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.

Rehabilitation Research Center (REVAL), Biomed, Hasselt University, Diepenbeek, Belgium.

出版信息

Dev Med Child Neurol. 2017 Feb;59(2):224-231. doi: 10.1111/dmcn.13277. Epub 2016 Sep 26.

DOI:10.1111/dmcn.13277
PMID:27671699
Abstract

AIM

To develop a patient-reported outcome measure (PROM) assessing upper limb function related to activities of daily living (ADL) that cannot be observed in a clinical setting, specifically for patients with Duchenne muscular dystrophy (DMD) across a wide age range, applicable in the different stages of the disease.

METHOD

The developmental process was based on US Food and Drug Administration guidelines. This included item generation from a systematic review of existing tools and expert opinion on task difficulty and relevance, involving individuals with DMD. Cultural aspects affecting ADL were taken into consideration to make this tool applicable to the broad DMD community. Items were selected in relation to a conceptual framework reflecting disease progression covering the full range of upper limb function across different ADL domains.

RESULTS

After pilot testing and iterative Rasch analyses, redundant or clinically irrelevant items were removed. The final questionnaire consists of 32 items covering four domains of ADL (food, self-care, household and environment, leisure and communication). Test-retest reliability was excellent.

INTERPRETATION

A DMD-specific upper limb PROM was developed on the basis of clinical relevance and psychometric robustness. Its main purpose is to document the patient self-reported natural history of DMD and assess the efficacy of interventions.

摘要

目的

开发一种患者报告结局量表(PROM),用于评估与日常生活活动(ADL)相关的上肢功能,这些功能在临床环境中无法观察到,特别是针对广泛年龄范围内的杜氏肌营养不良症(DMD)患者,适用于疾病的不同阶段。

方法

开发过程基于美国食品药品监督管理局的指南。这包括从对现有工具的系统评价以及关于任务难度和相关性的专家意见中生成条目,涉及DMD患者。考虑到影响ADL的文化因素,以使该工具适用于广泛的DMD群体。根据反映疾病进展的概念框架选择条目,该框架涵盖不同ADL领域的全范围上肢功能。

结果

经过预试验和迭代拉施分析,去除了冗余或临床无关的条目。最终问卷由32个条目组成,涵盖ADL的四个领域(饮食、自我护理、家庭与环境、休闲与交流)。重测信度极佳。

解读

基于临床相关性和心理测量稳健性开发了一种特定于DMD的上肢PROM。其主要目的是记录患者自我报告的DMD自然病史并评估干预措施的疗效。

相似文献

1
Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM.杜氏肌营养不良症上肢功能患者报告结局量表的开发:DMD上肢PROM
Dev Med Child Neurol. 2017 Feb;59(2):224-231. doi: 10.1111/dmcn.13277. Epub 2016 Sep 26.
2
Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy.上肢模块性能在杜氏肌营养不良症中的发展。
Dev Med Child Neurol. 2013 Nov;55(11):1038-45. doi: 10.1111/dmcn.12213. Epub 2013 Aug 1.
3
Instruments to assess upper-limb function in children and adolescents with neuromuscular diseases: a systematic review.评估神经肌肉疾病患儿上肢功能的工具:系统评价。
Dev Med Child Neurol. 2021 Sep;63(9):1030-1037. doi: 10.1111/dmcn.14887. Epub 2021 Apr 8.
4
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0.杜氏肌营养不良症上肢患者报告结局测量:与 PUL2.0 的相关性。
Neuromuscul Disord. 2023 Sep;33(9):69-73. doi: 10.1016/j.nmd.2023.07.003. Epub 2023 Jul 22.
5
Development and content validation of the Muscular Dystrophy Child Health Index of Life with Disabilities questionnaire for children with Duchenne muscular dystrophy.中文译文:《杜氏肌营养不良症儿童生活障碍残疾健康指数问卷》的编制及内容效度验证。
Dev Med Child Neurol. 2019 Jan;61(1):75-81. doi: 10.1111/dmcn.13977. Epub 2018 Jul 29.
6
Manual ability and upper limb performance in nonambulatory stage of Duchenne muscular dystrophy.杜氏肌营养不良非卧床期的手动能力和上肢表现。
Arch Pediatr. 2020 Aug;27(6):304-309. doi: 10.1016/j.arcped.2020.06.007. Epub 2020 Jul 24.
7
Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks.测量杜氏肌营养不良症的影响:从 PROMIS 项目库中开发一个代理报告的测量工具。
Orphanet J Rare Dis. 2021 Nov 22;16(1):487. doi: 10.1186/s13023-021-02114-7.
8
[Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy].[杜氏肌营养不良症和脊髓性肌萎缩症患儿上肢功能评估量表]
Rev Chil Pediatr. 2017 Feb;88(1):92-99. doi: 10.1016/j.rchipe.2016.07.003.
9
Towards a short questionnaire for stepwise assessment of upper limb function, pain and stiffness in Duchenne muscular dystrophy.迈向用于进行性肌营养不良症上肢功能、疼痛和僵硬逐步评估的简短问卷。
Disabil Rehabil. 2018 Apr;40(7):842-847. doi: 10.1080/09638288.2016.1274336. Epub 2017 Jan 13.
10
Reliability and validity of upper limb short questionnaire for Duchenne muscular dystrophy.杜氏肌营养不良症上肢短问卷的信度和效度。
Disabil Rehabil. 2022 Jun;44(11):2448-2455. doi: 10.1080/09638288.2020.1829107. Epub 2020 Oct 7.

引用本文的文献

1
Psychometric analysis of the patient-reported outcomes measurement information system parent proxy physical function-upper extremity item bank for children with Duchenne muscular dystrophy.杜氏肌营养不良症患儿患者报告结局测量信息系统家长代理上肢身体功能条目库的心理测量分析
Front Neurol. 2025 May 13;16:1481825. doi: 10.3389/fneur.2025.1481825. eCollection 2025.
2
Active, Actuated, and Assistive: a Scoping Review of Exoskeletons for the Hands and Wrists.主动、驱动和辅助:手部和腕部外骨骼的范围综述
Can Prosthet Orthot J. 2024 Nov 8;7(1):43827. doi: 10.33137/cpoj.v7i1.43827. eCollection 2024.
3
Relationship Between Hand Strength and Function in Duchenne Muscular Dystrophy and Spinal Muscular Atrophy: Implications for Clinical Trials.
杜氏肌营养不良症和脊髓性肌萎缩症的手部力量与功能之间的关系:对临床试验的影响。
J Neuromuscul Dis. 2024;11(4):777-790. doi: 10.3233/JND-230182.
4
Patient-Reported Outcome Measures in Neuromuscular Diseases: A Scoping Review.神经肌肉疾病患者报告的结局指标:一项范围综述
J Neuromuscul Dis. 2024;11(3):567-577. doi: 10.3233/JND-240003.
5
Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies - Developing Potential Treatments for the Entire Spectrum of Disease.行业指南草案:杜氏肌营养不良症、贝克肌营养不良症和相关肌营养不良症——为整个疾病谱开发潜在的治疗方法。
J Neuromuscul Dis. 2024;11(2):499-523. doi: 10.3233/JND-230219.
6
Design requirements of upper extremity supports for daily use in Duchenne muscular dystrophy with severe muscle weakness.杜氏肌营养不良症严重肌肉无力患者日常使用的上肢支撑装置的设计要求
J Rehabil Assist Technol Eng. 2024 Feb 8;11:20556683241228478. doi: 10.1177/20556683241228478. eCollection 2024 Jan-Dec.
7
Lessons Learned From Translational Research in Neuromuscular Diseases: Impact on Study Design, Outcome Measures and Managing Expectation.从神经肌肉疾病转化研究中吸取的经验教训:对研究设计、结局指标及期望管理的影响
Front Genet. 2021 Dec 7;12:759994. doi: 10.3389/fgene.2021.759994. eCollection 2021.
8
The involvement of rare disease patient organisations in therapeutic innovation across rare paediatric neurological conditions: a narrative review.罕见病患者组织参与罕见儿科神经疾病治疗创新:叙事性综述。
Orphanet J Rare Dis. 2022 Apr 18;17(1):167. doi: 10.1186/s13023-022-02317-6.
9
A Comparison of Caregiver and Patient Preferences for Treating Duchenne Muscular Dystrophy.照料者和患者对治疗杜氏肌营养不良症的偏好比较。
Patient. 2022 Sep;15(5):577-588. doi: 10.1007/s40271-022-00574-y. Epub 2022 Mar 4.
10
Fondazione Telethon and Unione Italiana Lotta alla Distrofia Muscolare, a successful partnership for neuromuscular healthcare research of value for patients.特龙基金会和意大利肌肉萎缩症防治协会,在神经肌肉健康研究方面的成功合作,为患者带来了有价值的成果。
Orphanet J Rare Dis. 2021 Oct 2;16(1):408. doi: 10.1186/s13023-021-02047-1.